Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
Hill

Congress enacted H.R. 8205, the ALS therapy access reauthorization act, which was signed into law as Public Law 119-138 on November 3, 2026.

Why it’s here: A federal bill reauthorizing ALS therapy access programs became public law, a direct US federal legislative action relevant to biotechnology policy.

Trace across the board

Item

Connected

1 links

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

Congress enacted H.R. 8205, the ALS therapy access reauthorization act, which was signed into law as Public Law 119-138 on November 3, 2026. — The Wave